Yonas M. Tesfamariam
Bonn, NW 53127, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Poxvirus dsDNA genomes differentially activate AIM2 or NLRP3 inflammasomes in human primary cells.
Journal: The EMBO journal
Published: November 08, 2024
Antagonistic nanobodies implicate mechanism of GSDMD pore formation and potential therapeutic application.
Journal: Nature communications
Published: March 12, 2024
Multi-omics characterization of the monkeypox virus infection.
Journal: Nature communications
Published: December 19, 2023
Inhibition of cellular RNA methyltransferase abrogates influenza virus capping and replication.
Journal: Science (New York, N.Y.)
Published: February 09, 2023
P38 kinases mediate NLRP1 inflammasome activation after ribotoxic stress response and virus infection.
Journal: The Journal of experimental medicine
Published: May 12, 2022
Nanobodies dismantle post-pyroptotic ASC specks and counteract inflammation in vivo.
Journal: EMBO molecular medicine
Published: November 10, 2021
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
Journal: The Cochrane database of systematic reviews
Published: December 03, 2020
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape.
Journal: Science (New York, N.Y.)
Published: September 04, 2020
Effects of oil substrate supplementation on production of prodigiosin by Serratia nematodiphila for dye-sensitized solar cell.
Journal: Journal of biotechnology
Published: August 07, 2019
Adjuvant bisphosphonates or RANK-ligand inhibitors for patients with breast cancer and bone metastases: A systematic review and network meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: August 27, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026